Hera Biotech

So proud to represent Hera Biotech and The Cedars-Sinai Accelerator at HLTH USA alongside Cinzia Donato this coming week! Hera is currently raising, so we're looking to meet with anyone who is looking for opportunities in women's health! You can book time with us here: https://lnkd.in/gdsKFJXc See you all next week!

I had such an amazing time speaking with Nicole Kalil and am so excited to have my episode of This is Women's Work podcast live! Always exciting to have the opportunity to talk about #womenshealth and where we need to be #investing! Link in the comments so you can give it a listen!

The predictive and diagnostic tools created by Class 10 address some of the most prevalent problems for everyday patients. Today, we are excited to introduce Healthplus.ai and Hera Biotech. Healthplus.ai is enabling proactive surgery care through personalized complication predictions. Healthplus.ai's CE IIa certified solution, PERISCOPE®, is an AI-based decision support tool that highly-accurately predicts infection risks using existing EHR data, facilitating early intervention, eliminating unnecessary hospital stays, and reducing readmissions. Healthplus.ai uses real-time data along with validated & locally recalibrated machine learning algorithms to integrate with the existing workflow to aid clinical staff, delivering proactive and individualized care. Hera Biotech offers the world’s first non-surgical test for endometriosis, the number one cause of female infertility. Hera's test, MetriDx™, provides definitive diagnosis and staging of endometriosis through tissue-based analysis. MetriDx™ measures the expression patterns of an endometriosis-specific gene panel. Hera Biotech's patent-protected panel is heavily based on the expression profiles of a gene set implicated in a number of other invasive processes. Hera Biotech primarily serves the OB/GYN and fertility solutions markets with its innovative diagnostic tool. #CSaccelerator #healthinnovate #healthaccelerator #HIT #healthdisruptors #CSAclass10

📢 Spotlight on pioneers in "AI applications in women's health" 📢 We are excited to share our newest report, "AI Applications in Women's Health". In this report, we highlight companies paving the way for better health outcomes for women by harnessing AI. Hera Biotech: Somer Baburek, MBA and the team at Hera are powering endometriosis diagnosis with AI. Evvy: Priyanka Jain and the team at Evvy have developed vaginal microbiome testing. Oviva Therapeutics: Daisy Robinton, PhD and the team at Oviva are increasing ovarian healthspan. WHOOP: Will Ahmed and the team at Whoop are supporting women with wearables to track their wellbeing. 🔗 Download the complete report to dive into details about the latest in the landscape of AI in women's health: https://lnkd.in/eKvt_HXq #femtech #DrB #Womenshealth #AI #Marketinsights

Please join us in welcoming and congratulating the digital health companies selected to join the Cedars-Sinai Accelerator's prestigious Class 10! From curated business sessions to meetings with various healthcare professionals from Cedars-Sinai and beyond, the Accelerator Program will offer these companies countless opportunities to promote their innovative solutions and learn how they can make an impact in the current healthcare landscape. Learn more about each company by reading the article below or checking out their company page. Class is almost in session! Welcome Class 10! Elaborate Fraiya Ltd Healthplus.ai Hera Biotech iCardio.ai Kinexcs Momentum Health Neu Health NOMA AI Pulse Charter Connect #CSaccelerator #healthinnovate #healthaccelerator #HIT #healthdisruptors #CSAclass10